DC Healthcare Holdings Berhad Reports Strong Q3 Performance
KUALA LUMPUR, MY / ACCESS Newswire / November 25, 2025 / DC Healthcare Holdings Berhad (“DC Healthcare” or the “Group“), a prominent provider of medical aesthetic services, has demonstrated impressive growth in its third-quarter financial performance for the period ending September 30, 2025 (“Q3 FY2025“). The company reported a Profit Before Tax (“PBT”) of RM3.06 million, marking a significant return to profitability.
Substantial Revenue Growth
The Group achieved a revenue of RM25.72 million in Q3 FY2025, reflecting a remarkable increase of 62.7% compared to RM15.81 million from the same period last year. This surge was primarily driven by the aesthetic services sector, which accounted for RM22.23 million or 86.4% of the total revenue, thanks to enhanced treatment redemptions and robust cash sales collections.
Improving Profitability Metrics
The significant turnaround from a Loss Before Tax (“LBT”) of RM2.15 million a year prior underscores the Group’s operational efficiency and effective cost management. The achievement of RM3.06 million in PBT reflects not only an improved service realization but also the successful implementation of ongoing operational strategies.
Solid Year-to-Date Performance
For the nine months ending September 30, 2025 (“9M FY2025“), DC Healthcare recorded a cumulative revenue of RM64.22 million, which represents a substantial increase of 64.1% over RM39.14 million from the same period last year (“9M FY2024“). The aesthetic services sector continued to spearhead this growth, rising sharply from RM32.16 million in 9M FY2024 to RM54.89 million in the current period, accompanied by a PBT of RM1.19 million.
Quarterly Momentum
On a quarter-on-quarter basis, the Group showcased strong momentum, with revenue climbing 24.9% from RM20.60 million in Q2 FY2025 to RM25.72 million in Q3 FY2025. This consistent earnings improvement presented a notable shift from a LBT of RM1.03 million in the previous quarter to a PBT of RM3.06 million in Q3 FY2025, owing to increased aesthetic service demand and the impact of the cost optimization program.
Vision from Leadership
Dr. Chong Tze Sheng, Managing Director of DC Healthcare, emphasized the importance of this quarterly achievement, stating that it embodies the strong demand for aesthetic services and the resilience of their operational model. He highlighted the Group’s commitment to leveraging technology and maintaining disciplined cost management to fuel future growth.
Strategic Focus and Future Initiatives
Looking ahead, DC Healthcare aims to strengthen its strategic pillars through the synergy of its core brands, including Dr. Chong Clinic, Dr. Chong Slimming, and NewB Premium Skincare. By incorporating artificial intelligence-enhanced skin analysis and personalized treatment plans, the Group seeks to enhance not only service accuracy but also customer retention.
Conclusion
In conclusion, DC Healthcare’s sustained operational excellence and strategic initiatives position the Company well to capitalize on the growing opportunities in Malaysia’s aesthetic and wellness market. As the Group focuses on enhancing its service offerings and cost structure, it remains poised for continued recovery in performance, making it an attractive prospect for investors interested in stocks in the healthcare sector.
ABOUT DC HEALTHCARE HOLDINGS BERHAD – “In safety we commit”
DC Healthcare Holdings Berhad is a leading provider of medical aesthetic and wellness services, specializing in non-invasive and minimally invasive procedures. The Group operates under various brands, including Dr Chong Clinic and Dr Chong Slimming, and is dedicated to advancing skills in the medical aesthetic field through its training center, DC Academy.
For more information, visit www.dchealthcareholdings.com.